GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom/Impact Scale (GODDESS(©)): psychometric properties and clinically meaningful thresholds as assessed in the Phase 3 DeFi randomized controlled clinical trial

PURPOSE: The GODDESS(©) tool was developed to assess Desmoid Tumor/Aggressive Fibromatosis (DT/AF) symptom severity and impact on patients’ lives. This study evaluated GODDESS(©)’s cross-sectional and longitudinal measurement properties. METHODS: The Phase 3, randomized placebo-controlled, DeFi stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Gounder, Mrinal M., Atkinson, Thomas M., Bell, Timothy, Daskalopoulou, Christina, Griffiths, Pip, Martindale, Moriah, Smith, L. Mary, Lim, Allison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474203/
https://www.ncbi.nlm.nih.gov/pubmed/37347393
http://dx.doi.org/10.1007/s11136-023-03445-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474203/
https://www.ncbi.nlm.nih.gov/pubmed/37347393
http://dx.doi.org/10.1007/s11136-023-03445-7

Ejemplares similares